Renal cancer

Bobby C. Liaw, Reza Mehrazin, Che Kai Tsao

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

1 Scopus citations


Renal cancers encompass a collection of different disease entities, the most common of which are renal cell carcinoma (RCC) and transitional cell carcinoma (TCC). RCC has multiple histologic subtypes which differ in clinical features and genomic findings, some of which are associated with hereditary syndromes. TCC resembles transitional-cell bladder cancer and is treated on the basis of its primary histology. While localized, both are primarily managed surgically. In advanced stages, RCC treatment is comprised of immunotherapeutic and molecularly targeted agents, whereas the mainstay of TCC management remains cytotoxic platinum-based chemotherapy regimens.

Original languageEnglish
Title of host publicationOncology
Number of pages13
ISBN (Electronic)9781119189596
ISBN (Print)9781119189558
StatePublished - 30 Aug 2019


  • Chromophobe
  • Clear cell
  • Immunotherapy
  • Non-clear cell
  • Oncocytoma
  • Renal cell carcinoma
  • Transitional cell carcinoma
  • Tyrosine kinase inhibitor
  • Vascular endothelial growth factor
  • mTOR inhibitor


Dive into the research topics of 'Renal cancer'. Together they form a unique fingerprint.

Cite this